These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21318860)

  • 21. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
    De Vos B; Han HH; Bouckenooghe A; Debrus S; Gillard P; Ward R; Cheuvart B
    Pediatr Infect Dis J; 2009 Apr; 28(4):261-6. PubMed ID: 19289978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically engineered structure-based vaccine for bluetongue disease.
    Roy P
    Vet Ital; 2004; 40(4):594-600. PubMed ID: 20422594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live attenuated human rotavirus vaccine, Rotarix.
    Bernstein DI
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
    Rennels MB; Glass RI; Dennehy PH; Bernstein DI; Pichichero ME; Zito ET; Mack ME; Davidson BL; Kapikian AZ
    Pediatrics; 1996 Jan; 97(1):7-13. PubMed ID: 8545227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotavirus vaccines for the developing world.
    O'Ryan ML; Hermosilla G; Osorio G
    Curr Opin Infect Dis; 2009 Oct; 22(5):483-9. PubMed ID: 19623063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
    Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
    Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses.
    Kawagishi T; Sánchez-Tacuba L; Feng N; Costantini VP; Tan M; Jiang X; Green KY; Vinjé J; Ding S; Greenberg HB
    Proc Natl Acad Sci U S A; 2023 Feb; 120(9):e2214421120. PubMed ID: 36821582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotavirus.
    Parashar UD; Bresee JS; Gentsch JR; Glass RI
    Emerg Infect Dis; 1998; 4(4):561-70. PubMed ID: 9866732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles.
    Hertel PM; Crawford SE; Bessard BC; Estes MK
    Vaccine; 2013 Nov; 31(48):5778-84. PubMed ID: 23887039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and immunological studies of rotavirus vaccines.
    Vesikari T
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):437-47. PubMed ID: 2851185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and prevention of rotavirus infection: an underestimated issue?
    Meloni A; Locci D; Frau G; Masia G; Nurchi AM; Coppola RC
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():48-51. PubMed ID: 21749188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. American Academy of Pediatrics.
    Pediatrics; 1998 Dec; 102(6):1483-91. PubMed ID: 9832589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rotavirus vaccines and vaccination potential.
    Conner ME; Matson DO; Estes MK
    Curr Top Microbiol Immunol; 1994; 185():285-337. PubMed ID: 8050282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine.
    Shahrudin S; Chen C; David SC; Singleton EV; Davies J; Kirkwood CD; Hirst TR; Beard M; Alsharifi M
    PLoS One; 2018; 13(6):e0198182. PubMed ID: 29879130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future rotavirus research.
    Desselberger U; Estes MK
    Methods Mol Med; 2000; 34():239-58. PubMed ID: 21318863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is a rhinovirus vaccine possible?
    Fox JP
    Am J Epidemiol; 1976 Apr; 103(4):345-54. PubMed ID: 176887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.